Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 10 results for "fresenius kabi oncology"

PFIZER : Fresenius Kabi Oncology Withdraws Patent Pleas Agains...

Crizotinib is branded as Xalkori, while Axitinib as Inlyta by Pfizer . Fresenius Kabi has informed its decision to withdraw four petitions against patent of Crizotinib and one against Axitinib with the Intellectual Property Appellate Board (IPAB) ... 4 Traders, 1 week ago
Fresenius Kabi withdraws patent pleas against Pfizer Financial Express, 2 weeks ago
Business Standard

Fresenius Kabi withdraws petitions against Pfizer cancer patents

Cancer drug major Fresenius Kabi Oncology Ltd, the Indian arm of Germany-based Fresenius Kabi, has withdrew revocation petitions against cancer drug patents owned by Pfizer and its subsidiaries as the former has "lost business interest" in the molecules. The ...
 Business Standard2 weeks ago

Pfizer inks COPD promo deal with Novartis in U.K.; Roche chair says no big mergers;

@FiercePharma: Tops on FPMarketing Weds: Can Sanofi/Regeneron's new data one-up Amgen in megablockbuster PCSK9 field? Article | Follow @FiercePharma @EricPFierce: Agents in EU seize €10M worth of counterfeit drugs, as well as cash and luxury ...
 FiercePharma1 week ago
European Medicines Agency

Pending EC decision: Busulfan Fresenius Kabi, Busulfan, Opinion date: 24-Jul-2014

the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Busulfan Fresenius Kabi intended for conditioning treatment prior to conventional ...
 European Medicines Agency1 month ago Xultophy, Accofil and Busulfan recommended by EMA/CHMP  Pharma Letter1 month ago News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 July 2014  European Medicines Agency1 month ago

CHMP Gives Nod to New Drugs in Cancer Care

Approval has been recommended for 2 new generic drugs that can be used in cancer treatment in the European Union, as has an expanded indication for a third drug. Marketing authorization has been recommended by the Committee for Medicinal Products ...
 American Journal of Public Health1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less